The Role of Pharmacy Benefit Managers

Date:

Wed, 09/11/2024 - 2:00 PM

Location:

2141 RHOB

Witnesses

Panel 1

Dr. Richard Frank

Director, Health Program

Frank Testimony

Frank Truth in Testimony

Dr. Anthony LoSasso

Professor and Chair, Department of Economics

LoSasso Testimony

LoSasso Truth in Testimony

Dr. T. Joseph Mattingly II

Associate Professor and Vice Chair of Research, College of Pharmacy

Mattingly Testimony

Mattingly Truth in Testimony

Dr. Karen Van Nuys

Executive Director, Value of Life Sciences Innovation

Van Nuys Testimony

Van Nuys Truth in Testimony

Meeting Documents

A report from Brookings titled, A brief look at current debates about pharmacy benefit managers, submitted for the Record by Mr. Correa of CA

A letter from California Life Sciences and California Pharmacists Association to members of the California Congressional Delegation regarding PBM reforms, submitted for the Record by Mr. Correa of CA

A report from Compass Lexecon titled, PBMs and Prescription Drug Distribution: An Economic Analysis of Criticisms Levied Against Pharmacy Benefit Managers, submitted for the Record by Mr. Correa of CA

A report from Drug Channels Institute titled, The 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers, submitted for the Record by Mr. Correa of CA

An article from The New York Times titled, The Opaque Industry Secretly Inflating Prices for Prescription Drugs, submitted for the Record by Mr. Correa of CA

A report from the Federal Trade Commission titled, Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies, submitted for the Record by Mr. Correa of CA

A letter dated June 5, 2024, from PhRMA to Assistant Attorney General Kanter, Secretary Becerra, and Chair Khan regarding the consolidation of the health care market, submitted for the Record by Mr. Correa of CA

An article from the Wall Street Journal titled, Mail-Order Drugs Were Supposed to Keep Costs Down. Its Doing the Opposite., submitted for the Record by Mr. Correa of CA

A statement of dissent dated July 9, 2024, from Commissioner Melissa Holyoak of the Federal Trade Commission in the matter of the Pharmacy Benefit Managers Report, submitted for the Record by Mr. Moran of TX

A question for the record to all witnesses, submitted for the Record by Mr. Correa of CA

Response to the question for the record from Dr. Mattingly

Response to the question for the record from Dr. Van Nuys

Response to the question for the record from Dr. LoSasso

Response to the question for the record from Dr. Frank